Q32 Bio Inc

Biotech Stocks Healthcare Stocks

$12.74

-1.40 (-9.90%)

As of Jun 30, 10:40 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +119.3% upside

Low Target $24.18

Average Target $27.94

High Target $39.76

Current Price $12.74

Current
$12.74

Target
$27.94

$24.18 $27.94 avg $39.76

Scenario Analysis

Bear Case

$24.18

89.8%

Low target

Base Case

$27.94

+119.3%

Avg target

Bull Case

$39.76

+212.1%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$14.85

-14.2% from high

52-Week Low

$1.35

+847.2% from low

Target vs 52W High

$27.94

+88.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%